Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario H Skiadopoulos

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Expert Review of Vaccines|October 30, 2016
Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal ruleJanice Longstreth, Mario H Skiadopoulos, Robert J Hopkins
Journal of Virology|October 17, 2006
Nonsegmented negative-strand viruses as vaccine vectorsAlexander Bukreyev, Mario H Skiadopoulos, Brian R Murphy, et al.
International Journal of Toxicology|June 11, 2019
Repeat-Dose Toxicity Study of a Lyophilized Recombinant Protective Antigen-Based Anthrax Vaccine Adjuvanted With CpG 7909Vladimir Savransky, Michael Lacy, Boris Ionin, et al.
Journal of Virological Methods|January 11, 2007
An improved method for the recovery of recombinant paramyxovirus vaccine candidates suitable for use in human clinical trialsSonja R Surman, Peter L Collins, Brian R Murphy, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2002
More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved?Alexander Bukreyev, Mario H Skiadopoulos, Josephine McAuliffe, et al.
Journal of Virological Methods|June 16, 2005
Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expressionStéphane Biacchesi, Mario H Skiadopoulos, Lijuan Yang, et al.
Journal of Virology|November 25, 2005
Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivoQuynh N Pham, Stéphane Biacchesi, Mario H Skiadopoulos, et al.
Journal of Virology|December 13, 2002
The genome length of human parainfluenza virus type 2 follows the rule of six, and recombinant viruses recovered from non-polyhexameric-length antigenomic cDNAs contain a biased distribution of correcting mutationsMario H Skiadopoulos, Leatrice Vogel, Jeffrey M Riggs, et al.
Virology|March 31, 2004
Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genesStéphane Biacchesi, Mario H Skiadopoulos, Kim C Tran, et al.
Journal of Virology|September 15, 2005
Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidatesStéphane Biacchesi, Quynh N Pham, Mario H Skiadopoulos, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Expert Review of Vaccines|October 30, 2016
Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal ruleJanice Longstreth, Mario H Skiadopoulos, Robert J Hopkins
Journal of Virology|October 17, 2006
Nonsegmented negative-strand viruses as vaccine vectorsAlexander Bukreyev, Mario H Skiadopoulos, Brian R Murphy, et al.
International Journal of Toxicology|June 11, 2019
Repeat-Dose Toxicity Study of a Lyophilized Recombinant Protective Antigen-Based Anthrax Vaccine Adjuvanted With CpG 7909Vladimir Savransky, Michael Lacy, Boris Ionin, et al.
Journal of Virological Methods|January 11, 2007
An improved method for the recovery of recombinant paramyxovirus vaccine candidates suitable for use in human clinical trialsSonja R Surman, Peter L Collins, Brian R Murphy, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2002
More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved?Alexander Bukreyev, Mario H Skiadopoulos, Josephine McAuliffe, et al.
Journal of Virological Methods|June 16, 2005
Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expressionStéphane Biacchesi, Mario H Skiadopoulos, Lijuan Yang, et al.
Journal of Virology|November 25, 2005
Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivoQuynh N Pham, Stéphane Biacchesi, Mario H Skiadopoulos, et al.
Journal of Virology|December 13, 2002
The genome length of human parainfluenza virus type 2 follows the rule of six, and recombinant viruses recovered from non-polyhexameric-length antigenomic cDNAs contain a biased distribution of correcting mutationsMario H Skiadopoulos, Leatrice Vogel, Jeffrey M Riggs, et al.
Virology|March 31, 2004
Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genesStéphane Biacchesi, Mario H Skiadopoulos, Kim C Tran, et al.
Journal of Virology|September 15, 2005
Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidatesStéphane Biacchesi, Quynh N Pham, Mario H Skiadopoulos, et al.
Pageof 5